These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34252608)

  • 1. Why Aren't We Achieving High Vaccination Rates for Rotavirus Vaccine in the United States?
    Kempe A; O'Leary ST; Cortese MM; Crane LA; Cataldi JR; Brtnikova M; Beaty BL; Hurley LP; Gorman C; Tate JE; St Pierre JL; Lindley MC
    Acad Pediatr; 2022; 22(4):542-550. PubMed ID: 34252608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):521-4. PubMed ID: 20448529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of rotavirus vaccine among US infants at Immunization Information System Sentinel Sites.
    Pringle K; Cardemil CV; Pabst LJ; Parashar UD; Cortese MM
    Vaccine; 2016 Dec; 34(50):6396-6401. PubMed ID: 27810316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance.
    Calnan M; Krishnarajah G; Duh MS; Haider BA; Yermakov S; Davis M; Yan S
    Hum Vaccin Immunother; 2016 May; 12(5):1235-43. PubMed ID: 26900728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccination in the US: a systematic review of vaccination coverage and completion.
    Ghaswalla PK; D'Angelo J; Abu-Elyazeed R
    Hum Vaccin Immunother; 2021 Mar; 17(3):872-879. PubMed ID: 32845792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccination compliance and completion in a Medicaid infant population.
    Krishnarajah G; Landsman-Blumberg P; Eynullayeva E
    Vaccine; 2015 Jan; 33(3):479-86. PubMed ID: 24962753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States.
    Krishnarajah G; Demissie K; Lefebvre P; Gaur S; Sheng Duh M
    Hum Vaccin Immunother; 2014; 10(8):2255-66. PubMed ID: 25424930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will pediatricians adopt the new rotavirus vaccine?
    Kempe A; Daley MF; Parashar UD; Crane LA; Beaty BL; Stokley S; Barrow J; Babbel C; Dickinson LM; Widdowson MA; Alexander JP; Berman S
    Pediatrics; 2007 Jan; 119(1):1-10. PubMed ID: 17200265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missed Opportunities for Rotavirus Vaccination.
    Sederdahl BK; Orenstein WA; Yi J; Anderson EJ; Bednarczyk RA
    Pediatrics; 2019 May; 143(5):. PubMed ID: 31023829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoption of rotavirus vaccination by pediatricians and family medicine physicians in the United States.
    Kempe A; Patel MM; Daley MF; Crane LA; Beaty B; Stokley S; Barrow J; Babbel C; Dickinson LM; Tempte JL; Parashar UD
    Pediatrics; 2009 Nov; 124(5):e809-16. PubMed ID: 19822592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States.
    Krishnarajah G; Duh MS; Korves C; Demissie K
    PLoS One; 2016; 11(1):e0145977. PubMed ID: 26751375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccination in Japan: Efficacy and safety of vaccines, changes in genotype, and surveillance efforts.
    Tsugawa T; Akane Y; Honjo S; Kondo K; Kawasaki Y
    J Infect Chemother; 2021 Jul; 27(7):940-948. PubMed ID: 33867267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a publicly funded monovalent rotavirus vaccination program in the Province of Quebec (Canada).
    Comeau JL; Gagneur A; Quach C
    Vaccine; 2016 Feb; 34(7):893-8. PubMed ID: 26795368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotarix® and RotaTeq® administration to preterm infants in the neonatal intensive care unit: Review of available evidence.
    Esposito S; Pugni L; Mosca F; Principi N
    Vaccine; 2018 Aug; 36(36):5430-5434. PubMed ID: 29037579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.
    Fathima P; Gidding HF; Snelling TL; McIntyre PB; Blyth CC; Sheridan S; Liu B; de Klerk N; Moore HC
    Vaccine; 2019 Sep; 37(39):5835-5843. PubMed ID: 31443995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico.
    Gomez J; Velázquez FR; Guzman-Holst A; Cervantes Apolinar MY; Van Bellinghen LA; Van Vlaenderen I; van Oorschot D
    Hum Vaccin Immunother; 2023 Aug; 19(2):2219189. PubMed ID: 37339232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.
    Li RC; Li YP; Mo ZJ; Luo D; Huang T; Kong JL; Wang LH; Song NS; Liu A; Zhang H; Liao X; Karkada N; Han HH
    Hum Vaccin Immunother; 2013 Aug; 9(8):1638-42. PubMed ID: 23807360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.